Clinical Trial Update: Atazanavir/r + Lamivudine Dual Therapy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update of Atazanavir/ritonavir plus Lamivudine as dual therapy for HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• Human Immunodeficiency Virus Infection

Drugs mentioned

• Atazanavir/ritonavir (atazanavir/ritonavir)
• Lamivudine (lamivudine)

Snippet

Sponsor: Catholic University of the Sacred Heart | Conditions: Human Immunodeficiency Virus | Phase 4 | Status: COMPLETED